Sage Therapeutics (SAGE) PT Lowered to $83 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $83.00 (from $85.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Gartner (IT) PT Lowered to $206 at BMO Capital, adjusting estimates
- Pony AI Inc (PONY) PT Lowered to $17 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
